Use Of Activated Charcoal To Reduce Elevated Serum Phenobarbital Concentration In A Neonate
- 1 January 1991
- journal article
- case report
- Published by Taylor & Francis in Journal of Toxicology: Clinical Toxicology
- Vol. 29 (1) , 53-58
- https://doi.org/10.3109/15563659109038597
Abstract
The course of a neonate administered activated charcoal orally for elevated phenobarbital concentration is described. The neonate required a serum concentration of phenobarbital eventually exceeding 80 micrograms/mL for seizure control. However, due to the severe CNS injury as a result of the asphyxia at birth, a diagnosis of cerebral death by electroencephalogram and apnea test was pursued. This required the phenobarbital concentration to be less than 30 micrograms/mL. Serial phenobarbital concentrations during this time indicated a 250 hour half-life, which would require two weeks for the phenobarbital to drop below 30 micrograms/mL. With the administration of six doses of activated charcoal at 0.7 g/kg/dose, the phenobarbital serum concentration decreased to 22 micrograms/mL, giving an estimated phenobarbital half-life of 22 hours. This, and two other subsequent cases, indicates repeated doses of activated charcoal are effective in augmenting the clearance of certain drugs in the neonatal age group.Keywords
This publication has 9 references indexed in Scilit:
- Multiple Dose Activated Charcoal for Theophylline Poisoning in Young InfantsPediatrics, 1987
- Acceleration of digoxin clearance by activated charcoalClinical Pharmacology & Therapeutics, 1985
- The Treatment of Tricyclic Antidepressant Overdose with Repeated CharcoalJournal of Clinical Psychopharmacology, 1984
- Model for theophylline overdose treatment with oral activated charcoalClinical Pharmacology & Therapeutics, 1984
- Acceleration of the Body Clearance of Phenobarbital by Oral Activated CharcoalNew England Journal of Medicine, 1982
- Effect of Administration of Activated Charcoal and Fibre on Absorption, Excretion and Steady State Blood Levels of Digoxin and Digitoxin. Evidence for Intestinal Secretion of the GlycosidesActa Medica Scandinavica, 1982
- Effect of activated charcoal on absorption and elimination of phenobarbitone, carbamazepine and phenylbutazone in manEuropean Journal of Clinical Pharmacology, 1980
- Inhibition of theophylline absorption by activated charcoalThe Journal of Pediatrics, 1979